| miR-17 |
Chemotherapy |
neuroblastoma |
Resistant |
Low |
18493594 |
|
| miR-21 |
Chemotherapy |
non-small cell lung cancer |
Resistant |
Low |
21627863 |
|
| miR-10b |
Chemotherapy |
pancreatic ductal adenocarcinoma |
Resistant |
Low |
21652542 |
|
| miR-221 |
Chemotherapy |
breast cancer |
Associated |
Low |
22156446 |
|
| miR-21 |
Chemotherapy |
colorectal cancer |
Associated |
Low |
22289545 |
|
| miR-21 |
Chemotherapy |
esophageal squamous cell carcinoma |
Resistant |
Low |
22354855 |
|
| let-7i |
Chemotherapy |
gastric cancer |
Sensitive |
Low |
23107361 |
|
| miR-21 |
Chemotherapy |
osteosarcoma |
Associated |
Low |
23321165 |
|
| miR-125b |
Chemotherapy |
breast cancer |
Resistant |
Low |
23606360 |
|
| miR-21 |
Chemotherapy |
colon cancer |
Associated |
Low |
24122631 |
|
| miR-27a |
Chemotherapy |
non-small cell lung cancer |
Associated |
Low |
24223174 |
|
| miR-19a |
Chemotherapy |
colorectal cancer |
Resistant |
Low |
24460313 |
|
| miR-132 |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-140 |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-143 |
Chemotherapy |
osteosarcoma |
Sensitive |
High |
24468065 |
|
| miR-145 |
Chemotherapy |
osteosarcoma |
Sensitive |
High |
24468065 |
|
| miR-15b |
Chemotherapy |
osteosarcoma |
Sensitive |
High |
24468065 |
|
| miR-17 |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-181a |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-200a |
Chemotherapy |
osteosarcoma |
Sensitive |
High |
24468065 |
|
| miR-200c |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-21 |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-215 |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-221 |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-23a |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-25 |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-26b |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-30a |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-34c |
Chemotherapy |
osteosarcoma |
Sensitive |
High |
24468065 |
|
| miR-363 |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-375 |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-422a |
Chemotherapy |
osteosarcoma |
Sensitive |
High |
24468065 |
|
| miR-451 |
Chemotherapy |
osteosarcoma |
Sensitive |
High |
24468065 |
|
| miR-611 |
Chemotherapy |
osteosarcoma |
Sensitive |
High |
24468065 |
|
| miR-625 |
Chemotherapy |
osteosarcoma |
Resistant |
High |
24468065 |
|
| miR-92a |
Chemotherapy |
osteosarcoma |
Sensitive |
High |
24468065 |
|
| miR-221 |
Chemotherapy |
glioma |
Resistant |
Low |
24589600 |
|
| miR-29b |
chemotherapy |
ovarian carcinoma |
Sensitive |
Low |
24767251 |
|
| miR-106b |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
Low |
24805828 |
|
| miR-152 |
Chemotherapy |
epithelial ovarian cancer |
Resistant |
Low |
24805828 |
|
| miR-200a |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
Low |
24805828 |
|
| miR-381 |
Chemotherapy |
epithelial ovarian cancer |
Resistant |
Low |
24805828 |
|
| miR-429 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
Low |
24805828 |
|
| miR-10b |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-10b* |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-1233 |
Chemotherapy |
epithelial ovarian cancer |
Resistant |
High |
24848511 |
|
| miR-129 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-135b |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-148a |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-182 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-183 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-193a |
Chemotherapy |
epithelial ovarian cancer |
Resistant |
High |
24848511 |
|
| miR-200b |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-22 |
Chemotherapy |
epithelial ovarian cancer |
Resistant |
High |
24848511 |
|
| miR-302b |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-30a* |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-33b |
Chemotherapy |
epithelial ovarian cancer |
Resistant |
High |
24848511 |
|
| miR-34b |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-371 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-424 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-431* |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-488 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-491 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-492 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-498 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-509-3 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-513a |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-517b |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-545 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-592 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-597 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-625* |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-628 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-629* |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-641 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-7 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-708 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-7-1* |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| miR-96 |
Chemotherapy |
epithelial ovarian cancer |
Sensitive |
High |
24848511 |
|
| let-7g* |
Chemotherapy |
colorectal cancer |
Sensitive |
High |
25197016 |
|
| miR-107 |
Chemotherapy |
colorectal cancer |
Sensitive |
High |
25197016 |
|
| miR-299 |
Chemotherapy |
colorectal cancer |
Sensitive |
High |
25197016 |
|
| miR-337 |
Chemotherapy |
colorectal cancer |
Sensitive |
High |
25197016 |
|
| miR-370 |
Chemotherapy |
colorectal cancer |
Sensitive |
High |
25197016 |
|
| miR-505* |
Chemotherapy |
colorectal cancer |
Sensitive |
High |
25197016 |
|
| miR-889 |
Chemotherapy |
colorectal cancer |
Resistant |
High |
25197016 |
|
| miR-99a |
Chemotherapy |
colorectal cancer |
Sensitive |
High |
25197016 |
|
| miR-145 |
chemotherapy |
non-small cell lung cancer |
Sensitive |
Low |
25661374 |
|
| miR-335 |
chemotherapy |
acute myeloid leukemia |
Resistant |
Low |
26287405 |
|
